Chinese humanoid robotics maker Unitree filed for its IPO, joining an historic pipeline of new issues. Demand is reportedly running roughly 8,000 times oversubscribed, and the shockwave is already showing up in humanoid-themed ETFs. The Roundhill Humanoid Robotics ETF (NASDAQ:HUMN) has climbed about 10% YTD and is up roughly 25% over the past year, outpacing the broader robotics complex. With just $46.5 million in net assets spread across 40 holdings, HUMN is still small enough for a sustained rush into pure-play humanoid names to move the needle quickly.
Three Ways to Play the Humanoid Theme
HUMN is the most concentrated humanoid bet on the market. Tesla co-anchors the book at roughly 4.1% of net assets, preceded only by Hong Kong-listed humanoid developer UBTech at 5%. The top holdings roster is rounded out by XPeng. Roughly 60% of the portfolio sits in non-US listings, heavy in China, Japan, and South Korea.
The KraneShares Global Humanoid Robotics and Physical AI Index ETF (NASDAQ:KOID) offers a similar pure-play angle at a net expense ratio of 0.69% (0.79% gross), and it has been the momentum leader with a 22.4% year-to-date gain and a 39.0% return over the past year.
For investors who want robotics exposure with less speculative torque, the Global X Robotics & Artificial Intelligence ETF (NASDAQ:BOTZ) is the incumbent. It manages $3.74 billion and leans heavily on industrial automation giants: Keyence at about 9%, ABB at roughly 9%, FANUC at nearly 9%, and NVIDIA at about 8%. Direct humanoid names like UBTech and Serve Robotics combine for barely 2% of assets. BOTZ is up about 12% over the past year, which tells you the humanoid narrative is not really driving this fund.
The Macro Factor: US-China Tech Policy
The macro variable most likely to reshape HUMN and KOID over the next 12 months is U.S.-China trade and technology policy. Several of HUMN’s largest China-based holdings with humanoid exposure, including UBTech, Dobot, Xiaomi and XPeng, could be vulnerable if the Commerce Department expands its Entity List to include Chinese robotics developers or the U.S. imposes new tariffs on robotic components. BOTZ’s Japanese and European industrial base would be largely untouched.
Investors should watch Federal Register notices, updates to the Bureau of Industry and Security’s Entity List and any U.S. Trade Representative Section 301 review involving advanced manufacturing. Huawei’s 2019 designation showed how quickly Chinese technology stocks in Hong Kong and the U.S. can reprice after Washington redraws the lines. For HUMN holders, policy could turn today’s thematic tailwind into tomorrow’s drawdown.
The Fund-Specific Factor: Tesla and Rebalance Risk
HUMN’s biggest idiosyncratic risk is Tesla concentration. Tesla is HUMN’s second-largest holding at 4.12%, behind UBTech Robotics at about 5.%. That gives Optimus production updates an important role in the fund’s performance without turning HUMN into a Tesla proxy. NVIDIA accounts for another 2.81%, while the rest of the portfolio reaches across robotics manufacturers, component suppliers and automation specialists.
The next rebalance will show how quickly HUMN makes room for the emerging pure plays. If Unitree, Figure AI or other humanoid specialists enter after going public, they could displace established technology and industrial holdings. KOID’s methodology already leans further toward direct humanoid exposure, which is part of why it has run ahead of HUMN year to date.
What to Watch Next
The next leg of the humanoid trade rests on two forces investors can track: Washington and Tesla. If Chinese developers stay off the Entity List through year-end and Tesla reaffirms its Optimus volume-production timeline, HUMN and KOID should retain their edge over BOTZ. If either signal turns negative, BOTZ’s industrial ballast may offer the safer route into robotics. The humanoids will keep multiplying. Policy and production will decide which fund wins the trade.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks